
Our list of Immunology antibodies has been created for your convenience. For the month of August, the Immunology Collection will be discounted 15% off in support of Immunization Awareness month. Click on any target for more information.
TARGET
AIF1
AIM2
APG5L
APG7
ATG12
ASK1 Thr845
ATG1/ULK1
ATG1 Ser556
ATG9B
ATG13
ATG16 Ser287
ATG16L
Beclin 1
c-Raf/Raf1
CCL5/RANTES
CCR7/CD197
CD4
CD8
CD8
CD8B
CD14
CD19
CD31
CD45
CD62L
CD134
CD142
CD150
CD160/By55
CD161c/NK1.1
CD200
IL-12RB1/CD212
CD272
PD-1/CD279
Complement C2
Complement C3
Complement C4/C4
Complement factor 8 beta
Complement fragment 3c
CTLA4
CXCR1
CXCR2/CD182
CXCR3/CD183
CXCR3
CXCR4
CXCR5/CD185
CXCR7/RDC1
ERK1 + 2
ERK1/2 Thr202 + Tyr204
human Fibrinogen
GM-CSF
GM-CSF
GM-CSFR alpha
GSK3 Alpha Ser21
IFN gamma
IFN gamma
IKK alpha
IL-1 Beta
IL-1R1
IL-1R1 Tyr496
IL-1R2
IL-2
IL-2
IL-2R gamma
IL2RA
AIF1
AIM2
APG5L
APG7
ATG12
ASK1 Thr845
ATG1/ULK1
ATG1 Ser556
ATG9B
ATG13
ATG16 Ser287
ATG16L
Beclin 1
c-Raf/Raf1
CCL5/RANTES
CCR7/CD197
CD4
CD8
CD8
CD8B
CD14
CD19
CD31
CD45
CD62L
CD134
CD142
CD150
CD160/By55
CD161c/NK1.1
CD200
IL-12RB1/CD212
CD272
PD-1/CD279
Complement C2
Complement C3
Complement C4/C4
Complement factor 8 beta
Complement fragment 3c
CTLA4
CXCR1
CXCR2/CD182
CXCR3/CD183
CXCR3
CXCR4
CXCR5/CD185
CXCR7/RDC1
ERK1 + 2
ERK1/2 Thr202 + Tyr204
human Fibrinogen
GM-CSF
GM-CSF
GM-CSFR alpha
GSK3 Alpha Ser21
IFN gamma
IFN gamma
IKK alpha
IL-1 Beta
IL-1R1
IL-1R1 Tyr496
IL-1R2
IL-2
IL-2
IL-2R gamma
IL2RA
APPLICATION
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, IHC, ICC
WB, ELISA, IHC
WB, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC
WB
IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, IHC, ICC
WB, ELISA, IHC
WB, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC
WB
IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM
WB, ELISA, FCM, IHC
TARGET
IL-3
IL4R
IL-6
IL-6
IL-8
IL-9
IL-10
IL-10
IL10RB
IL-12
IL-12 alpha
IL-12 beta
IL12RB2
IL-15RA
IL-17
IL-17
IL-17B
IL-17C
IL17RA/CD217
IL-17RB
IL-18R Beta/CD218b
IL-21
Insulin
IRAK1
JNK1+2+3
JNK1+2+3 (THR183+TYR185)
LAMP-1
LAMP2
LC3A/B
Lymphocyte Activation Gene 3
Lyn
Lyn
MIP 1 gamma
MAPKAP Kinase 2
MAPKAPK2 Thr222
MEK1
MEK1/2 Ser218 + Ser222
MEK5
MLK3 Thr277 + Ser281
MyD88
NEDD4
NFkB Inducing Kinase NIK
NFKB p65
NFKB p105 / p50
NFKBIA/IKB alpha
P38 MAPK
p38 MAPK Thr180 + Tyr182
PLCG 2
STAT5
TLR1
TLR2
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TNF alpha
TNF-alpha
TNFRSF18
TNFSF18
TNFSF9/CD137L
TRADD
TRAF3
IL-3
IL4R
IL-6
IL-6
IL-8
IL-9
IL-10
IL-10
IL10RB
IL-12
IL-12 alpha
IL-12 beta
IL12RB2
IL-15RA
IL-17
IL-17
IL-17B
IL-17C
IL17RA/CD217
IL-17RB
IL-18R Beta/CD218b
IL-21
Insulin
IRAK1
JNK1+2+3
JNK1+2+3 (THR183+TYR185)
LAMP-1
LAMP2
LC3A/B
Lymphocyte Activation Gene 3
Lyn
Lyn
MIP 1 gamma
MAPKAP Kinase 2
MAPKAPK2 Thr222
MEK1
MEK1/2 Ser218 + Ser222
MEK5
MLK3 Thr277 + Ser281
MyD88
NEDD4
NFkB Inducing Kinase NIK
NFKB p65
NFKB p105 / p50
NFKBIA/IKB alpha
P38 MAPK
p38 MAPK Thr180 + Tyr182
PLCG 2
STAT5
TLR1
TLR2
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TNF alpha
TNF-alpha
TNFRSF18
TNFSF18
TNFSF9/CD137L
TRADD
TRAF3
APPLICATION
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IP
WB, ELISA, IHC
IHC, ICC
ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, IP
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, FCM, IHC, ICC
WB, ELISA
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, FCM, IHC-P, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, IHC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC
WB, ELISA, FCM, IP
WB, ELISA, IHC
IHC, ICC
ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, IP
WB, ELISA, FCM, IHC, ICC
ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
ELISA, FCM, IHC, ICC
WB, ELISA
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, FCM, IHC-P, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, FCM, IHC, ICC
WB, ELISA, IHC
WB, IHC
ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, IHC, ICC
WB, ELISA, FCM, IHC, ICC